0001209191-21-064924.txt : 20211116 0001209191-21-064924.hdr.sgml : 20211116 20211116201752 ACCESSION NUMBER: 0001209191-21-064924 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211116 FILED AS OF DATE: 20211116 DATE AS OF CHANGE: 20211116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LOWE CHRISTOPHER P. CENTRAL INDEX KEY: 0001376260 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38890 FILM NUMBER: 211418040 MAIL ADDRESS: STREET 1: 2511 N LOOP 1604, STREET 2: SUITE 204 CITY: SAN ANTONIO STATE: TX ZIP: 78258 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cortexyme, Inc. CENTRAL INDEX KEY: 0001662774 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 269 EAST GRAND AVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-910-5717 MAIL ADDRESS: STREET 1: 269 EAST GRAND AVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-11-16 0 0001662774 Cortexyme, Inc. CRTX 0001376260 LOWE CHRISTOPHER P. C/O CORTEXYME, INC. 269 EAST GRAND AVE. SOUTH SAN FRANCISCO CA 94080 0 1 0 0 COO & Chief Financial Officer Common Stock 2021-11-16 4 M 0 30000 2.23 A 90000 D Stock Option (right to buy) 2.23 2021-11-16 4 M 0 30000 0.00 D 2028-11-27 Common Stock 30000 103294 D The option will vest as to 25% of the shares on November 15, 2019, with the remaining 75% of shares vesting in equal monthly installments beginning on December 15, 2019 and ending on November 15, 2022. /s/ Caryn McDowell, Attorney-in-Fact for Christopher Lowe 2021-11-16